Daniel Menichella

2020

In 2020, Daniel Menichella earned a total compensation of $3.9M as President and Chief Executive Officer principal executive officer at Kaleido Biosciences.

Compensation breakdown

Non-Equity Incentive Plan$49,044
Option Awards$3,777,318
Salary$118,731
Other$1,734
Total$3,946,827

Menichella received $3.8M in option awards, accounting for 96% of the total pay in 2020.

Menichella also received $49K in non-equity incentive plan, $118.7K in salary and $1.7K in other compensation.

Rankings

In 2020, Daniel Menichella's compensation ranked 2,890th out of 13,090 executives tracked by ExecPay. In other words, Menichella earned more than 77.9% of executives.

ClassificationRankingPercentile
All
2,890
out of 13,090
78th
Division
Manufacturing
1,113
out of 5,621
80th
Major group
Chemicals And Allied Products
413
out of 2,254
82nd
Industry group
Drugs
357
out of 1,954
82nd
Industry
Biological Products, Except Diagnostic Substances
93
out of 411
77th
Source: SEC filing on May 5, 2021.

Menichella's colleagues

We found three more compensation records of executives who worked with Daniel Menichella at Kaleido Biosciences in 2020.

2020

Katharine Knobil

Kaleido Biosciences

Chief Marketing Officer

2020

William Duke

Kaleido Biosciences

Chief Financial Officer

2020

Alison Lawton

Kaleido Biosciences

Chief Executive Officer

News

In-depth

You may also like